JOSE LUIS
LLORENTE PENDAS
Catedrático de Universidad
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2022
-
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma
European Journal of Cancer, Vol. 162, pp. 221-236